Edwards Lifesciences Corp. is no longer acquiring structural heart company JenaValve Technology for $945 million after a U.S. District Court granted the Federal Trade Commission’s motion for an ...
LAS VEGAS — In the high-energy gaming halls of CES 2026, where the latest virtual reality headsets and haptic vests compete for attention, a quiet breakthrough from Scotland is promising to change how ...
Edwards Lifesciences (EW) said it will no longer pursue the acquisition of heart device developer JenaValve Technology after a federal court in Columbia ruled against the MedTech giant in a case ...
On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district court injunction blocking implementation of HRSA’s 340B Rebate Model Pilot ...
Loyalty programs remain a powerful tool for businesses. According to last year’s Statista survey, a third of marketers believe their company earns five to seven times more from these programs than it ...
WASHINGTON -- Beyond taking a tough stance toward big tech companies, the Federal Trade Commission under U.S. President Donald Trump also plans aggressive steps to bring down "the cost of living for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results